We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$10.3B
AUM Growth
+$326M
Cap. Flow
-$31.7M
Cap. Flow %
-0.31%
Top 10 Hldgs %
48.58%
Holding
592
New
32
Increased
94
Reduced
135
Closed
27

Top Buys

Rank Stock Value
1
WSE
Wise Group
WSE
+$52.3M
2
LLY icon
Eli Lilly
LLY
+$21M
3
NVDA icon
NVIDIA
NVDA
+$17.5M
4
ASML icon
ASML
ASML
+$16.9M
5
AVGO icon
Broadcom
AVGO
+$16.3M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$57.6M
2
ADBE icon
Adobe
ADBE
+$24.5M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$24.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$19.1M
5
QCOM icon
Qualcomm
QCOM
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 32.07%
2 Healthcare 15.31%
3 Consumer Discretionary 12.49%
4 Communication Services 12.1%
5 Financials 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAX icon
476
Baxter International
BAX
$13.9B
$26.1K ﹤0.01%
1,225
TTEK icon
477
Tetra Tech
TTEK
$9.32B
$26K ﹤0.01%
900
FDXF
478
FedEx Freight
FDXF
$22.5B
$25.2K ﹤0.01%
+167
New +$27.4K
ACWI icon
479
iShares MSCI ACWI ETF
ACWI
$33.6B
$25.1K ﹤0.01%
160
IJT icon
480
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$25K ﹤0.01%
140
-1,200
-90% -$194K
TKO icon
481
TKO Group
TKO
$14.5B
$24.2K ﹤0.01%
120
OXY.WS icon
482
Occidental Petroleum Corp Warrants
OXY.WS
$33.7B
0
KMI icon
483
Kinder Morgan
KMI
$71.5B
$22.1K ﹤0.01%
691
CME icon
484
CME Group
CME
$95.8B
$22.1K ﹤0.01%
100
TFC icon
485
Truist Financial
TFC
$64.7B
$21.9K ﹤0.01%
440
COO icon
486
Cooper Companies
COO
$15B
$21.3K ﹤0.01%
297
BF.B icon
487
Brown-Forman Class B
BF.B
$12.8B
$21.3K ﹤0.01%
799
DUK icon
488
Duke Energy
DUK
$97B
$21.3K ﹤0.01%
168
FMS icon
489
Fresenius Medical Care
FMS
$12.6B
$20.9K ﹤0.01%
926
CDZI icon
490
Cadiz
CDZI
$295M
$20.9K ﹤0.01%
5,000
ONON icon
491
On Holding
ONON
$10.5B
$20.9K ﹤0.01%
590
TTWO icon
492
Take-Two Interactive
TTWO
$45.4B
$19K ﹤0.01%
76
SCZ icon
493
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$18.9K ﹤0.01%
230
EPD icon
494
Enterprise Products Partners
EPD
$82.2B
$18.4K ﹤0.01%
500
BNTX icon
495
BioNTech
BNTX
$23.1B
$17.7K ﹤0.01%
190
VSTM icon
496
Verastem
VSTM
$607M
$17.2K ﹤0.01%
4,500
MNST icon
497
Monster Beverage
MNST
$91.5B
$17.1K ﹤0.01%
356
DG icon
498
Dollar General
DG
$27B
$16.9K ﹤0.01%
147
APTV icon
499
Aptiv
APTV
$10.1B
$16.7K ﹤0.01%
272
VDE icon
500
Vanguard Energy ETF
VDE
$10.4B
$16.2K ﹤0.01%
108

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Loring Wolcott & Coolidge Fiduciary Advisors held 592 positions worth $10.3B, up 3.3% from $9.98B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2026 filing shows 32 new, 94 increased, 135 reduced and 27 closed positions. Its largest new stake was Wise Group: 4,378,556 shares worth $52.1M. The largest sale was Booking.com, an estimated $57.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2026 buy was Wise Group: 4,378,556 shares worth $52.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Eli Lilly in Q2 2026, an estimated $21M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2026 reduction was Booking.com, cutting an estimated $57.6M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited RenaissanceRe in Q2 2026, selling an estimated $1.2M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 49% of its $10.3B portfolio in Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 32 new positions and closed 27 in Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 3.3% quarter-over-quarter to $10.3B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.